Key Takeaways GLP-1 weight loss drugs appear to help battle alcoholismRegular drinkers taking GLP-1 drugs experienced a 68% ...

Liraglutide and semaglutide reduce alcohol intake, cutting it by nearly two-thirds within four months of treatment.

New study finds weight loss jabs not only help tackle obesity but may significantly reduce alcohol use, offering wide health ...

My doctor said patients have told him they were able to stop drinking and even quit cocaine use while taking Wegovy.

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

In the early days of the semaglutide weight loss wave, many of its users reported less interest in alcohol. A study now says ...

The study showed that Glucagon-like peptide-1 (GLP-1) analogues — drugs developed to treat obesity — likely curb alcohol ...

Weight loss jabs could help slash alcohol intake in obese people by around two thirds, according to a study. It is thought ...

Weight loss drugs could “revolutionise the treatment of alcohol use disorder” by “effortlessly” slashing the amount that ...

Essentially, Ozempic and Wegovy are brand names for semaglutide, which is in the GLP-1 receptor agonist (GLP-1RA) drug class.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Weight loss jabs could help reduce alcohol consumption in obese people by around two thirds, a new study suggests.